• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method.

作者信息

Armson A, Meloni B P, Reynoldson J A, Thompson R C

机构信息

WHO Collaborating Centre for the Molecular Epidemiology fo Parasitic, Infections, Division of Veterinary and Biomedical Sciences, Murdoch University, Perth, WA, Austraila.

出版信息

FEMS Microbiol Lett. 1999 Sep 15;178(2):227-33. doi: 10.1111/j.1574-6968.1999.tb08681.x.

DOI:10.1111/j.1574-6968.1999.tb08681.x
PMID:10499272
Abstract

A rapid semi-quantitative screening method was devised for assessing the anticryptosporidial and cytotoxic effects of putative chemotherapeutic compounds. The method is suitable as an initial rapid screening procedure from which compounds demonstrating anticryptosporidial activity can be identified for further analysis. It has the advantages of speed, low cost and concurrent assessment of anticryptosporidial and cytotoxic effects and allows accurate determination of minimum lethal concentrations. Of the 71 compounds screened, six completely inhibited cryptosporidial growth at 1 microM (monensin, salinomycin, alborixin, lasalocid, trifluralin and nicarbazin) and a further eight showed significant anticryptosporidial activity at 1 or 20 microM (halquinol, bleomycin, suramin, mitomycin, doxycycline hydrochloride, toltrazuril, chloroquine phosphate and teniposide). Twelve compounds were found to have some degree of cytotoxicity at 1 microM and a further 12 at 20 microM.

摘要

相似文献

1
Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method.
FEMS Microbiol Lett. 1999 Sep 15;178(2):227-33. doi: 10.1111/j.1574-6968.1999.tb08681.x.
2
High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR.通过qRT-PCR对体外抗微小隐孢子虫生长的药物进行高通量筛选
Methods Mol Biol. 2020;2052:319-334. doi: 10.1007/978-1-4939-9748-0_18.
3
In vitro anticryptosporidial activity of dinitroaniline herbicides.二硝基苯胺类除草剂的体外抗隐孢子虫活性
FEMS Microbiol Lett. 1996 Mar 1;136(3):245-9. doi: 10.1111/j.1574-6968.1996.tb08056.x.
4
In vitro assessment of anticryptosporidial efficacy and cytotoxicity of adenosine analogues using a SYBR Green real-time PCR method.采用 SYBR Green 实时 PCR 方法评估腺苷类似物的抗隐孢子虫功效和细胞毒性的体外研究。
J Antimicrob Chemother. 2011 Mar;66(3):560-3. doi: 10.1093/jac/dkq522. Epub 2011 Jan 19.
5
Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model.博贝尔-24在细胞培养和严重联合免疫缺陷小鼠模型中对微小隐孢子虫的活性。
Antimicrob Agents Chemother. 2008 Mar;52(3):1150-2. doi: 10.1128/AAC.01019-07. Epub 2007 Dec 26.
6
Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.天然多糖壳聚糖对新生小鼠体内外微小隐孢子虫的疗效
Exp Parasitol. 2018 Nov;194:1-8. doi: 10.1016/j.exppara.2018.09.003. Epub 2018 Sep 17.
7
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics.单独及与其他肽类和疏水性抗生素联合使用时蛙皮抗菌肽的体外抗隐孢子虫活性
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):827-9. doi: 10.1007/s100960050410.
8
Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations.双环和三环二氨基嘧啶衍生物作为微小隐孢子虫二氢叶酸还原酶的有效抑制剂:构效关系和构选关系
Antimicrob Agents Chemother. 2001 Dec;45(12):3293-303. doi: 10.1128/AAC.45.12.3293-3303.2001.
9
Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents.
J Eukaryot Microbiol. 1994 Sep-Oct;41(5):39S.
10
Evaluation of putative anti-cryptosporidial drugs in an in vitro culture system.在体外培养系统中评估潜在的抗隐孢子虫药物。
Parasitol Res. 2013 Aug;112 Suppl 1:149-62. doi: 10.1007/s00436-013-3439-7.

引用本文的文献

1
Molecular identification and antiprotozoal activity of silver nanoparticles on viability of Cryptosporidium parvum isolated from pigeons, pigeon fanciers and water.对来自鸽子、鸽友和水中的微小隐孢子虫的银纳米粒子的生存能力的分子鉴定和抗原生动物活性。
Sci Rep. 2023 Feb 22;13(1):3109. doi: 10.1038/s41598-023-30270-2.
2
Anti-protozoal activity of Thymol and a Thymol ester against Cryptosporidium parvum in cell culture.百里酚及其酯类化合物在细胞培养中抗微小隐孢子虫的活性。
Int J Parasitol Drugs Drug Resist. 2021 Apr;15:126-133. doi: 10.1016/j.ijpddr.2021.02.003. Epub 2021 Feb 18.
3
Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.
评估细胞培养的微小隐孢子虫囊包和自由悬浮的微小隐孢子虫卵囊的 DNA 含量之间的差异,以及它们作为 qPCR 中 DNA 标准的适用性。
Parasit Vectors. 2019 Dec 19;12(1):596. doi: 10.1186/s13071-019-3851-7.
4
Discovery of Novel Anti-cryptosporidial Activities From Natural Products by High-Throughput Phenotypic Screening.通过高通量表型筛选从天然产物中发现新型抗隐孢子虫活性
Front Microbiol. 2019 Aug 29;10:1999. doi: 10.3389/fmicb.2019.01999. eCollection 2019.
5
Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.壳聚糖纳米粒子对微小隐孢子虫卵囊的抑制活性。
Parasitol Res. 2019 Jul;118(7):2053-2063. doi: 10.1007/s00436-019-06364-0. Epub 2019 Jun 11.
6
Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.油酰磷酸胆碱(OlPC)可在体外抑制微小隐孢子虫的生长,并预防干扰素γ受体基因敲除小鼠的致死性感染。
Front Microbiol. 2015 Sep 23;6:973. doi: 10.3389/fmicb.2015.00973. eCollection 2015.
7
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.隐孢子虫的全球负担、新型诊断方法、治疗方法及疫苗靶点综述
Lancet Infect Dis. 2015 Jan;15(1):85-94. doi: 10.1016/S1473-3099(14)70772-8. Epub 2014 Sep 29.
8
A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.一种半胱氨酸蛋白酶抑制剂可使小鼠从致死性微小隐孢子虫感染中获救。
Antimicrob Agents Chemother. 2013 Dec;57(12):6063-73. doi: 10.1128/AAC.00734-13. Epub 2013 Sep 23.
9
Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.药物重定位筛选揭示了 FDA 批准的人 HMG-CoA 还原酶和异戊烯合成抑制剂可阻断微小隐孢子虫的生长。
Antimicrob Agents Chemother. 2013 Apr;57(4):1804-14. doi: 10.1128/AAC.02460-12. Epub 2013 Feb 4.
10
In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds.植物源提取物和化合物抗隐孢子虫活性的体外测定。
Parasitol Res. 2012 Jul;111(1):231-40. doi: 10.1007/s00436-012-2824-y. Epub 2012 Jan 26.